TheProfitWatch

SONN - Sonnet BioTherapeutics Holdings, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.3 -0.16 (-3.72%) --- --- --- 0.05 (1.16%) -0.46 (-10.41%) 0.12 (2.99%) 0.12 (2.99%)

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.89
Diluted EPS:
-0.89
Basic P/E:
-4.6517
Diluted P/E:
-4.6517
RSI(14) 1m:
100.0
VWAP:
4.14
RVol:

Events

Period Kind Movement Occurred At

Related News